Trial Profile
Phase I trial of GSK 1614235 [DSP 3235] in Japan.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2012
Price :
$35
*
At a glance
- Drugs GSK 1614235 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions